One-year supplementation with Lactobacillus reuteri ATCC PTA 6475 counteracts a degradation of gut microbiota in older women with low bone mineral density

Abstract

Recent studies have shown that probiotic supplementation has beneficial effects on bone metabolism. In a randomized controlled trial (RCT) we demonstrated that supplementation of Lactobacillus reuteri ATCC PTA 6475 reduced bone loss in older women with low bone mineral density. To investigate the mechanisms underlying the effect of L. reuteri ATCC PTA 6475 on bone metabolism, 20 women with the highest changes (good responders) and the lowest changes (poor responders) in tibia total volumetric BMD after one-year supplementation were selected from our previous RCT. In the current study we characterized the gut microbiome composition and function as well as serum metabolome in good responders and poor responders to the probiotic treatment as a secondary analysis. Although there were no significant differences in the microbial composition at high taxonomic levels, gene richness of the gut microbiota was significantly higher (P < 0.01 by the Wilcoxon rank-sum test) and inflammatory state was improved (P < 0.05 by the Wilcoxon signed-rank test) in the good responders at the end of the 12-month daily supplementation. Moreover, detrimental changes including the enrichment of E. coli (adjusted P < 0.05 by DESeq2) and its biofilm formation (P < 0.05 by GSA) observed in the poor responders were alleviated in the good responders by the treatment. Our results indicate that L. reuteri ATCC PTA 6475 supplementation has the potential to prevent a deterioration of the gut microbiota and inflammatory status in elderly women with low bone mineral density, which might have beneficial effects on bone metabolism.

Beneficial effects of the probiotics and synbiotics supplementation on anthropometric indices and body composition in adults: A systematic review and meta‐analysis

“…Next, we removed 421 studies due to the following reasons: lack of required data as indicated in the inclusion/exclusion criteria, not having an appropriate control group, and co‐supplementation of probiotics and/or synbiotics with other active ingredients. However, there were some studies that were removed due to having the same sample of participants 60–83 and hence were treated as a single study. Finally, 200 unique RCTs with 220 effect sizes were included for quantitative and qualitative analysis.…”

Identifying microbial signatures for patients with postmenopausal osteoporosis using gut microbiota analyses and feature selection approaches

“…In most related studies, supplementation with probiotics increased BMD values ( Yu et al, 2021 ). For example, supplementation with Lactobacillus reuteri ATCC PTA 6475 reduced bone loss in older women with low BMD ( Li et al, 2022 ). Lactobacillus acidophilus inhibited bone loss and increased bone heterogeneity by modulating Treg-Th17 cell function in osteoporotic mice ( Dar et al, 2018 ).…”

Bones and guts – Why the microbiome matters

“…A decade of research focused on understanding gut-osteoporosis crosstalk has yielded some success alleviating osteoporosis by manipulating the gut. For example, Lactobacillus reuteri ATCC PTA 675 supplementation was found to enrich short chain fatty acids (SCFAs) and reduce detrimental bacteria in the gut [31] . Importantly, gut metabolites such as SCFAs may be a key to understanding gut-bone crosstalk.…”